Tumor (%ID/g) | 6.35 ± 2.23 | 2.84 ± 1.65 | 3.39 ± 0.85 | 1.34 ± 0.34 |
Blood (%ID) | 0.46 ± 0.20 | 0.42 ± 0.10 | 0.03 ± 0.02 | 0.03 ± 0.02 |
Liver (%ID) | 0.25 ± 0.08 | 0.26 ± 0.07 | 0.21 ± 0.36 | 0.03 ± 0.01 |
Kidneys (%ID) | 2.95 ± 0.79 | 1.57 ± 0.32 | 0.91 ± 0.25 | 0.38 ± 0.08 |
Pancreas (%ID) | 17.78 ± 4.07 | 6.44 ± 2.81 | 12.28 ± 3.50 | 0.21 ± 0.11 |
GI (%ID) | 11.22 ± 3.29 | 9.70 ± 1.24 | 5.77 ± 1.79 | 1.72 ± 0.30 |
Skin (%ID/g) | 0.33 ± 0.13 | 0.42 ± 0.33 | 0.10 ± 0.02 | 0.03 ± 0.01 |
Muscle (%ID/g) | 0.09 ± 0.02 | 0.15 ± 0.07 | 0.03 ± 0.02 | 0.02 ± 0.01 |
Bladder/urine (%ID) | 55.66 ± 7.28 | 57.88 ± 7.06 | NA | NA |
177Lu-AMBA, blocking studies (1 h) | Tumor (%ID/g) | Kidney (%ID) | Pancreas (%ID) | GI (%ID) |
+ 4 mg/kg AMBA (n = 5) | 1.09 ± 0.38* | 1.37 ± 0.15† | 0.14 ± 0.04* | 0.50 ± 0.12* |
+ 10 mg/kg AMBA (n = 5) | 0.82 ± 0.32* | 1.28 ± 0.31* | 0.10 ± 0.03* | 0.46 ± 0.08* |